School of Medicine
Showing 11-17 of 17 Results
-
Jennifer Rose-Nussbaumer
Alan Adler Global Ophthalmology Professor
BioJennifer Rose-Nussbaumer is a board-certified ophthalmologist and fellowship-trained cornea specialist at the Byers Eye Institute at Stanford University. Her clinical practice focuses on corneal transplant, complex cataract surgery and treatment of infectious keratitis. After completing her fellowship in Cornea and External Disease at the University of California, San Francisco, she stayed on faculty and remained there until she transitioned to Stanford in 2021. She continues to collaborate closely with the FI Proctor Foundation as an Associate Proctor Researcher.
In addition to her clinical work, Dr. Rose-Nussbaumer is an NIH-funded researcher who focuses on randomized clinical trials in ophthalmology. She is the PI on a UG1 grant, Descemet Endothelial Thickness Comparison Trial (DETECT), a randomized clinical trial comparing UT-DSAEK to DMEK and ripasudil versus placebo in patients with endothelial disease such as Fuchs Endothelial Dystrophy. She is also the PI on the Steroids and Cross-linking for Ulcer Treatment Trial (SCUT II), a randomized clinical trial in collaboration with Aravind Eye hospital in India and the University of Sao Paulo looking at the benefit of adjunctive topical steroids, corneal crosslinking or rose bengal photodynamic therapy in the treatment of infectious ulcers.
As a native of Northern California, she loves spending time with her family and Bernese Mountain Dog, Kenji, exploring California's natural beauty through hiking and camping. -
Charles William Ryan
Postdoctoral Scholar, Ophthalmology
BioI was born and raised in Syracuse, New York. I first attended Onondaga Community College, where I developed a fascination with the development of complex biological systems, and then transferred to Syracuse University where I completed my B.S. in biochemistry. I next attended the University of Michigan MD/PhD program, where I used in-vitro models of human neurodevelopment to study to role of epigenetic marks in guiding neurogenesis. While at Michigan, I became interested in the prospect of harnessing in-vitro differentiation to cultivate functional tissues that can be transplanted to replace what is lost in degenerative conditions. Ophthalmology, with its microsurgical access to functionally critical cell layers, is well-positioned to capitalize on this emerging field of science to treat degenerative conditions. I am humbled and incredibly thankful to have the opportunity to pursue this aim as a SOAR resident at Stanford.
